Studies related to Psoriasis and Zinc

Treatment Of Localized Psoriasis With A Topical Formulation Of Zinc Pyrithione

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 60
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
Twice daily topical application of a 0.25% zinc pyrithione cream for three months in persons with psoriasis is associated with up to 70.5% reduced symptomology (placebo experienced a 9.3% reduction).